FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122626653> ?p ?o ?g. }

• W2122626653 endingPage "634" @default.
• W2122626653 startingPage "629" @default.
• W2122626653 abstract "The presence of antibodies to cardiolipin (ACL Abs) has been reported in some patients suffering from multiple sclerosis (MS), especially of the “neuromyelitic” type. In addition, bright T2-imaging foci (unidentified bright objects) are occasionally detected on brain magnetic resonance imaging (MRI) scans, in patients with antiphospholipid syndrome. From a cohort of 100 patients with a probable or definite diagnosis of MS according to Poser's criteria, we isolated a subgroup of 20 patients (8 males and 12 females) consistently positive for ACL Abs. These patients were followed up neurologically for 1 to 3 years and brain MRI scanning and a complete autoimmune screening were performed. Nineteen (19 of 20) of our patients had the classic neuroimaging features of MS (multiple white-matter T2 bright foci on the MRI scan). The most common neurological syndrome was chronic, slowly progressing myelopathy (presenting as myelopathy, neuromyelitis optica, or spinocerebellar syndrome; 15 of 20), and optic neuropathy (6 of 20). Headache was a dominant symptom in 8 of 20 patients. Less common symptoms included cognitive and psychiatric disorders and chronic fatigue. The mean levels of ACL Abs were 38.8 ± 28.2 GPL (normal values up to 7.5). Oligoclonal bands in the cerebrospinal fluid were detected in only 3 of 20 patients. Patients were treated with acetylsalycilic acid and occasionally with short courses of steroids. The progression of the chronic myelopathic/spinocerebellar syndrome was slower than expected in MS (only 2 patients deteriorated whereas 4 improved during a mean follow-up period of 20.8 ± 7.1 months). We conclude that patients with probable or definite diagnosis of MS, and consistently elevated levels of ACL Abs show a slower progression and some atypical (for MS) features, such as persistent headaches and absence of oligoclonal bands in the cerebrospinal fluid. In these patients, other, presumably vascular, mechanisms may be involved in the pathogenesis of the neurological symptoms. Therefore, management should include antiplatelet or even anticoagulant agents." @default.
• W2122626653 created "2016-06-24" @default.
• W2122626653 creator A5015804063 @default.
• W2122626653 creator A5028133447 @default.
• W2122626653 creator A5059195767 @default.
• W2122626653 creator A5070259129 @default.
• W2122626653 date "1998-10-01" @default.
• W2122626653 modified "2023-09-29" @default.
• W2122626653 title "A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?" @default.
• W2122626653 cites W129707890 @default.
• W2122626653 cites W1832155548 @default.
• W2122626653 cites W1967553728 @default.
• W2122626653 cites W1969533338 @default.
• W2122626653 cites W1973354852 @default.
• W2122626653 cites W1991423145 @default.
• W2122626653 cites W2000201643 @default.
• W2122626653 cites W2001611219 @default.
• W2122626653 cites W2010526369 @default.
• W2122626653 cites W2017599164 @default.
• W2122626653 cites W2029590565 @default.
• W2122626653 cites W2030269528 @default.
• W2122626653 cites W2040236551 @default.
• W2122626653 cites W2041516872 @default.
• W2122626653 cites W2053238140 @default.
• W2122626653 cites W2061236212 @default.
• W2122626653 cites W2078344511 @default.
• W2122626653 cites W2081017805 @default.
• W2122626653 cites W2089593019 @default.
• W2122626653 cites W2095398342 @default.
• W2122626653 cites W2097396829 @default.
• W2122626653 cites W2101831374 @default.
• W2122626653 cites W2109451688 @default.
• W2122626653 cites W2112165124 @default.
• W2122626653 cites W2130355701 @default.
• W2122626653 cites W2139330614 @default.
• W2122626653 cites W2149567495 @default.
• W2122626653 cites W2334369045 @default.
• W2122626653 cites W2412812920 @default.
• W2122626653 cites W2417377791 @default.
• W2122626653 cites W2443941861 @default.
• W2122626653 cites W2596337489 @default.
• W2122626653 cites W2786338479 @default.
• W2122626653 cites W2925097035 @default.
• W2122626653 cites W4243571685 @default.
• W2122626653 cites W74356965 @default.
• W2122626653 doi "https://doi.org/10.1002/ana.410440408" @default.
• W2122626653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9778261" @default.
• W2122626653 hasPublicationYear "1998" @default.
• W2122626653 type Work @default.
• W2122626653 sameAs 2122626653 @default.
• W2122626653 citedByCount "112" @default.
• W2122626653 countsByYear W21226266532012 @default.
• W2122626653 countsByYear W21226266532013 @default.
• W2122626653 countsByYear W21226266532014 @default.
• W2122626653 countsByYear W21226266532015 @default.
• W2122626653 countsByYear W21226266532016 @default.
• W2122626653 countsByYear W21226266532017 @default.
• W2122626653 countsByYear W21226266532018 @default.
• W2122626653 countsByYear W21226266532019 @default.
• W2122626653 countsByYear W21226266532020 @default.
• W2122626653 countsByYear W21226266532021 @default.
• W2122626653 countsByYear W21226266532022 @default.
• W2122626653 countsByYear W21226266532023 @default.
• W2122626653 crossrefType "journal-article" @default.
• W2122626653 hasAuthorship W2122626653A5015804063 @default.
• W2122626653 hasAuthorship W2122626653A5028133447 @default.
• W2122626653 hasAuthorship W2122626653A5059195767 @default.
• W2122626653 hasAuthorship W2122626653A5070259129 @default.
• W2122626653 hasConcept C118552586 @default.
• W2122626653 hasConcept C126322002 @default.
• W2122626653 hasConcept C126838900 @default.
• W2122626653 hasConcept C142724271 @default.
• W2122626653 hasConcept C143409427 @default.
• W2122626653 hasConcept C146638467 @default.
• W2122626653 hasConcept C187382586 @default.
• W2122626653 hasConcept C203014093 @default.
• W2122626653 hasConcept C2776874634 @default.
• W2122626653 hasConcept C2777185649 @default.
• W2122626653 hasConcept C2777604421 @default.
• W2122626653 hasConcept C2779651940 @default.
• W2122626653 hasConcept C2780640218 @default.
• W2122626653 hasConcept C2780775167 @default.
• W2122626653 hasConcept C2780868729 @default.
• W2122626653 hasConcept C2781028063 @default.
• W2122626653 hasConcept C2781137167 @default.
• W2122626653 hasConcept C58693492 @default.
• W2122626653 hasConcept C71924100 @default.
• W2122626653 hasConcept C90924648 @default.
• W2122626653 hasConceptScore W2122626653C118552586 @default.
• W2122626653 hasConceptScore W2122626653C126322002 @default.
• W2122626653 hasConceptScore W2122626653C126838900 @default.
• W2122626653 hasConceptScore W2122626653C142724271 @default.
• W2122626653 hasConceptScore W2122626653C143409427 @default.
• W2122626653 hasConceptScore W2122626653C146638467 @default.
• W2122626653 hasConceptScore W2122626653C187382586 @default.
• W2122626653 hasConceptScore W2122626653C203014093 @default.
• W2122626653 hasConceptScore W2122626653C2776874634 @default.
• W2122626653 hasConceptScore W2122626653C2777185649 @default.

• next